A safety and performance study was performed in Jeroen Bosch hospital and the first global commercial implants took place in Elisabeth-TweeSteden hospital, The Netherlands
Sirius Medical is present at EBCC-12 conference with a virtual booth. Please visit us in this unique interactive environment to learn more about the Sirius Pintuition System.
Sirius Medical is excited to announce that it has successfully raised €4.4M to accelerate the commercial launch of the Sirius Pintuition System for cancer localization and to develop a pipeline of complementary products and indications.
Sirius Medical announces CE mark for Pintuition: a non-radioactive localization system to improve breast cancer surgery
Sirius Medical, a MedTech startup, announced that it has received CE mark approval for Sirius Pintuition.
Today, Sirius Medical announces that Dr. Tibor Kovacs, Prof Isabel Rubio and Prof Jos van der Hage will join its clinical advisory board for marker-based tumor localization.
Today, Sirius Medical proudly announces that it has received ISO 13485:2016 certification for its Quality Management System (QMS) following review by its notified body, DEKRA.